Effect of Induction Therapy on Graft Survival in Primary Pediatric Heart Transplantation

Transplantation - Tập 101 Số 6 - Trang 1228-1233 - 2017
Ryan J. Butts1,2, Melanie Davis3, Andrew Savage1, Ali Burnette4, Minoo N. Kavarana5, Scott M. Bradley5, Andrew M. Atz1, Paul J. Nietert3
1Division of Cardiology, Department of Pediatrics, Medical University of South Carolina, Charleston, SC
2Ryan Butts, MD, 165 Ashley Avenue, 601 Children's Hospital, Charleston, SC 29425. ([email protected]).
3Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC
4Department of Transplant Services, Medical University of South Carolina, Charleston, SC.
5Department of Surgery, Medical University of South Carolina, Charleston, SC

Tóm tắt

Từ khóa


Tài liệu tham khảo

Marshall, 2013, A comparison of traditional versus contemporary immunosuppressive regimens in pediatric heart recipients, J Pediatr, 163, 132, 10.1016/j.jpeds.2012.12.075

Boucek, 1999, Induction immunotherapy in pediatric heart transplant recipients: a multicenter study, J Heart Lung Transplant, 18, 460, 10.1016/S1053-2498(98)00076-X

Chin, 2005, Induction therapy for pediatric and adult heart transplantation: comparison between OKT3 and daclizumab, Transplantation, 80, 477, 10.1097/01.tp.0000168153.50774.30

Di Filippo, 2003, Rabbit antithymocyte globulin as induction immunotherapy in pediatric heart transplantation, Transplantation, 75, 354, 10.1097/01.TP.0000045223.66828.FA

Singh, 2010, Safety and early outcomes using a corticosteroid-avoidance immunosuppression protocol in pediatric heart transplant recipients, J Heart Lung Transplant, 29, 517, 10.1016/j.healun.2009.11.601

Gajarski, 2011, Infection and malignancy after pediatric heart transplantation: the role of induction therapy, J Heart Lung Transplant, 30, 299, 10.1016/j.healun.2010.09.005

Butts, 2014, Association of human leukocyte antigen donor-recipient matching and pediatric heart transplant graft survival, Circ Heart Fail, 7, 605, 10.1161/CIRCHEARTFAILURE.113.001008

Castleberry, 2014, Transplantation in the highly sensitized pediatric patient, Circulation, 129, 2313, 10.1161/CIRCULATIONAHA.113.001378

Butts, 2015, Validation of a Simple Score to Determine Risk of Early Rejection after Pediatric Heart Transplantation, JACC Heart Fail, 3, 670, 10.1016/j.jchf.2015.04.014

Rossano, 2010, Impact of antibodies against human leukocyte antigens on long-term outcome in pediatric heart transplant patients: an analysis of the United Network for Organ Sharing database, J Thorac Cardiovasc Surg, 140, 691, 10.1016/j.jtcvs.2010.04.009

Dipchand, 2013, The registry of the international society for heart and lung transplantation: sixteenth official pediatric heart transplantation report-2013; focus theme: age, J Heart Lung Transplant, 32, 979, 10.1016/j.healun.2013.08.005

Webber, 2003, Late rejection episodes more than 1 year after pediatric heart transplantation: risk factors and outcomes, J Heart Lung Transplant, 22, 869, 10.1016/S1053-2498(02)00819-7

Kirklin, 1992, Rejection after cardiac transplantation. A time-related risk factor analysis, Circulation, 86, II236

Kubo, 1995, Risk factors for late recurrent rejection after heart transplantation: a multiinstitutional, multivariable analysis. Cardiac Transplant Research Database Group, J Heart Lung Transplant, 14, 409

Grundy, 2009, Pre-implantation basiliximab reduces incidence of early acute rejection in pediatric heart transplantation, J Heart Lung Transplant, 28, 1279, 10.1016/j.healun.2009.09.001